Learn more about Peter Attia’s digital program
Rapamycin: one of my favorite stories; Ryan Lochte’s flip side on missing Olympic redemption
A few things worth checking out: 07-18-2021
Protecting against hearing loss
Considerations to protect the ability to hear across a lifespan
Three years behind the podcast mic
Asking for your feedback
Brain implants and identity; recovering a fallen Marine’s Purple Heart
A few things worth checking out: 06-27-2021
Are continuous glucose monitors a waste of time for people without diabetes?
Some experts suggest CGMs are useless for nondiabetics. I disagree.
A hope for treating Alzheimer’s disease?
The FDA approves the first new medication for AD, aducanumab, in two decades
D-Day: June 6, 1944
Commemorating a pivotal day of World War II
MDMA for PTSD?
MDMA-assisted therapy gets one step closer to its projected 2023 FDA approval
Psilocybin for depression?
The psychedelic drug goes head-to-head with Lexapro in a recent trial
How teeth sense cold; the efficacy of digital advertising
A few things worth checking out: 05-16-2021